About malignant pleural effusion
A pleural effusion is an abnormal amount of fluid in between the thin layers of tissue (pleura) lining the lung and the wall of the chest (pleural) cavity. If cancerous cells are found in this fluid, it is called a malignant pleural effusion. Lung cancer and breast cancer account for about 50-65% of malignant pleural effusions. Other common causes include pleural mesothelioma and lymphoma.
Mesothelioma is a rare cancer of the serous membranes, which enclose a number of organs throughout the midsection of the body. The most common type of mesothelioma, pleural mesothelioma, affects the serous membranes (lining) of the lungs. According to the National Cancer Institute (NCI), exposure to airborne asbestos particles increases one's risk of developing malignant mesothelioma. About 3,000 new cases of mesothelioma are diagnosed each year in the United States.
For more information about mesothelioma please visit the Mesothelioma Applied Research Foundation, www.curemeso.org, or the National Cancer Institute's Malignant Mesothelioma Home page, http://www.cancer.gov/cancertopics/types/malignantmesothelioma.
About non-small cell lung cancer
According to the American Cancer Society 2012 statistics, NSCLC is the most common type of lung cancer, comprising about 85% of all lung cancers. Squamous cell carcinoma, adenocarcinoma, and large cell carcinoma are all subtypes of NSCLC. Lung cancer is by far the leading cause of cancer death among both men and women. Each year, more people die of lung cancer than of colon, breast, and prostate cancers combined.
About Genelux Corporation
Headquartered in San Diego, California, Genelux Corporation is a privately held, clinical stage biopharmaceutical company dedicated to fundamentally changing the way in which cancer is diagnosed and treated. The company has developed a proprietary oncolytic vaccinia virus-based technology platform that can be engineered to insert specific therapeutic genes for delivery and amplification of anti-cancer proteins and RNA into cancer cells without harming healthy cells. This platform also includes a bioluminescent diagnostic, green fluorescent protein (GFP). The company is also incorporating advanced diagnostic deep-tissue imaging technologies into its viral platform to enable highly specific visualization of tumors and circulating cancer cells. GL-ONC1, the company's lead oncology product candidate, is an attenuated vaccinia virus (Lister strain) that is currently under evaluation in multiple human clinical trials in the US and Europe. For more information please visit http://www.genelux.com.
Genelux Forward Looking Statement
Statements made about Genelux Corporation, other than statements of historical fact, reflect Management's current beliefs and assumptions founded on the data and information currently available to us. Statements of the company's progress, results, timing of pre-clinical and clinical trials and projections for product pipelines are examples of forward-looking statements. By definition, such undertakings involve risks, uncertainties and assumptions, and are subject to a number of such factors that could cause actual results to differ substantially from statements made, including but not limited to: risks associated with the success of clinical trials, research and development programs, regulatory approval processes for clinical trials, competitive technologies and products, patents, inception and/or continuation of corporate and other strategic partnerships and the need for additional funding or financing.
(1 ) http://lungcancer.about.com/gi/o.htmzi=1/XJ&zTi=1&sdn=lungcancer&cdn=health&tm=100&f=00&su=p284.13.342.ip_p1026.33.342.ip_&tt=2&bt=1&bts=1&zu=http%3A//www.ncbi.nlm.nih.gov/pubmed/19436206%3Fordinalpos%3D10%26itool%3DEntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Most Popular Stories
- NSA Defends Global Cellphone Tracking Legality
- Top Websites for U.S. Hispanics
- Ad Counts Rise in 2013 for Hispanic Magazines
- Networks Vie for U.S. Hispanic TV Viewers
- Saab Gets Back into the Game; U.S. Auto Sales Soar
- Apple Activates Customer-Tracking iBeacon
- A Biography of Jonathan Ive, Apple's Creative Chief
- 2013 Tech Gift Guide: iPad Mini Still Hot; Chromecast a Great Low-Cost Option
- Dell Offers Undisclosed Number of Employee Buyouts
- Authorities Close to Deal with JPMorgan Chase over Madoff Response